Metropolitan Life Insurance Co NY lessened its holdings in LHC Group, Inc. (NASDAQ:LHCG) by 6.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,357 shares of the health services provider’s stock after selling 678 shares during the quarter. Metropolitan Life Insurance Co NY’s holdings in LHC Group were worth $1,037,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of the stock. Parallel Advisors LLC boosted its stake in shares of LHC Group by 790.0% during the first quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock worth $30,000 after buying an additional 237 shares during the period. Sageworth Trust Co acquired a new stake in shares of LHC Group during the first quarter worth about $36,000. Quadrant Capital Group LLC boosted its stake in shares of LHC Group by 1,045.7% during the first quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock worth $57,000 after buying an additional 481 shares during the period. Meeder Asset Management Inc. acquired a new stake in shares of LHC Group during the first quarter worth about $68,000. Finally, Private Capital Group LLC boosted its stake in shares of LHC Group by 24.4% during the first quarter. Private Capital Group LLC now owns 1,116 shares of the health services provider’s stock worth $124,000 after buying an additional 219 shares during the period. 91.43% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ:LHCG traded up $1.82 during trading on Thursday, reaching $123.34. The company had a trading volume of 130,800 shares, compared to its average volume of 246,290. LHC Group, Inc. has a twelve month low of $80.84 and a twelve month high of $128.31. The firm has a market cap of $3.83 billion, a price-to-earnings ratio of 34.74, a PEG ratio of 2.05 and a beta of 0.81. The business’s fifty day moving average is $118.09. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.57 and a quick ratio of 1.57.
In related news, Director John L. Indest sold 30,515 shares of the company’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $113.76, for a total transaction of $3,471,386.40. Following the completion of the sale, the director now directly owns 22,947 shares of the company’s stock, valued at approximately $2,610,450.72. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Ronald T. Nixon sold 12,000 shares of the company’s stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $117.20, for a total transaction of $1,406,400.00. Following the sale, the director now directly owns 29,100 shares of the company’s stock, valued at $3,410,520. The disclosure for this sale can be found here. Insiders have sold 46,269 shares of company stock worth $5,314,613 in the last 90 days. 5.20% of the stock is owned by company insiders.
A number of equities research analysts recently commented on LHCG shares. Royal Bank of Canada raised their price objective on shares of NVIDIA to $200.00 and gave the company an “outperform” rating in a research report on Monday, May 13th. BidaskClub downgraded shares of Ames National from a “hold” rating to a “sell” rating in a research report on Wednesday. UBS Group set a $133.00 price objective on shares of LHC Group and gave the company a “buy” rating in a research report on Friday, May 10th. Zacks Investment Research downgraded shares of Green Plains from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 27th. Finally, Jefferies Financial Group set a €28.00 ($32.56) price target on shares of Hamburger Hafen und Logistik and gave the company a “buy” rating in a research report on Thursday, May 9th. Three analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $120.58.
LHC Group Company Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Recommended Story: Why do analysts give a neutral rating?
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.